EuroInf 2: subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease (2019)
Source: Movement disorders. Unidade: FM
Subjects: ESTIMULAÇÃO CEREBRAL, FÁRMACOS (SISTEMA NERVOSO CENTRAL), AGENTES DOPAMINÉRGICOS, QUALIDADE DE VIDA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DAFSARI, Haidar S et al. EuroInf 2: subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease. Movement disorders, v. 34, n. 3, p. 353-365, 2019Tradução . . Disponível em: https://doi.org/10.1002/mds.27626. Acesso em: 13 maio 2024.APA
Dafsari, H. S., Martinez-Martin, P., Rizos, A., Trost, M., Ghilardi, M. G. dos S., Reddy, P., et al. (2019). EuroInf 2: subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease. Movement disorders, 34( 3), 353-365. doi:10.1002/mds.27626NLM
Dafsari HS, Martinez-Martin P, Rizos A, Trost M, Ghilardi MG dos S, Reddy P, Sauerbier A, Petry-Schmelzer JN, Kramberger M, Borgemeester RWK. EuroInf 2: subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease [Internet]. Movement disorders. 2019 ; 34( 3): 353-365.[citado 2024 maio 13 ] Available from: https://doi.org/10.1002/mds.27626Vancouver
Dafsari HS, Martinez-Martin P, Rizos A, Trost M, Ghilardi MG dos S, Reddy P, Sauerbier A, Petry-Schmelzer JN, Kramberger M, Borgemeester RWK. EuroInf 2: subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease [Internet]. Movement disorders. 2019 ; 34( 3): 353-365.[citado 2024 maio 13 ] Available from: https://doi.org/10.1002/mds.27626
